Cancer Cells Neutralise Formaldehyde Via Cystine Uptake
Researchers identify an NRF2-regulated defence that cancer cells use against a naturally produced toxic compound.
Updated on Nov. 18, 2026 in Cancer

Researchers at the Josep Carreras Leukaemia Research Institute have identified a mechanism that allows cancer cells to neutralise formaldehyde through cystine uptake. Blocking this pathway killed leukaemia and several solid tumour cell types when combined with inhibition of glutathione production.
Why it matters
Formaldehyde is naturally produced inside cells and can damage DNA, so a defence that protects tumour cells could be a target for new treatments. The findings also suggest that using glutathione for this purpose may leave cells less protected against ferroptosis.
The evidence comes from laboratory studies of cancer cells and an association found in myeloid leukaemia patients, where higher SLC7A11 levels were linked to poorer survival. The research team plans to investigate whether disrupting this defence mechanism could form the basis of a treatment, and that work is not yet complete.
The players
Josep Carreras Leukaemia Research Institute
A research institution in Spain that focuses on leukaemia and related blood cancers and led the study.
The details
NRF2 increases production of SLC7A11, a transporter that brings cystine into cells, where it is converted into cysteine. Cysteine reacts directly with formaldehyde to form thioproline, which was detected in cancer cells, and this route avoids using up glutathione. In cells exposed to high formaldehyde, blocking SLC7A11 triggered cell death.
Timeline
Study findings were reported on 18 November 2026.
Health Landscape
The finding adds to a growing body of research on how cancer cells manage metabolic stress, and it builds on earlier work from the Josep Carreras Leukaemia Research Institute on glutathione and ferroptosis in leukaemia. It points toward metabolic defence pathways as a possible target alongside existing approaches that focus on cell signalling.
At this stage the findings are laboratory-based and do not change how cancer is treated or diagnosed. Patients should continue to follow their oncologists' advice, as any treatment based on this mechanism would require further research and clinical testing before it could be used.
The takeaway
Metabolic defences such as cystine uptake may help tumour cells survive, and blocking them could become part of future cancer research. Readers should treat these results as early-stage science rather than a new treatment.
Further reading
Explore more research on Cancer to see how metabolic pathways are being studied as treatment targets.



